Literature DB >> 2741627

Incidence of anal epidermoid carcinoma in Sweden 1970-1984.

S Goldman1, B Glimelius, B Nilsson, L Påhlman.   

Abstract

A retrospective study was made of 858 cases of anal epidermoid carcinoma notified to the Swedish Cancer Registry in the 15-year period 1970-1984. The mean age at diagnosis was 67 years, with 5% (45) of the patients aged 25-44, 37% (314) aged 45-64 and 58% (499) greater than or equal to 65 years. All three age groups showed female predominance (c. 2:1), and the mean annual age-adjusted incidence/100,000 population was 1.40 for women and 0.68 for men. Incidence was highest in the cities of Stockholm (1.89) and Malmö (1.53). A strongly positive correlation was found between incidence of the disease and proportion of the population living in urban areas. Substantial annual rise (mean 4.3%) in incidence occurred during the study period, approximately the same in both sexes, in all age groups and in different "risk areas".

Entities:  

Mesh:

Year:  1989        PMID: 2741627

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  12 in total

Review 1.  Anal squamous cell carcinoma in a patient with Peutz-Jeghers syndrome.

Authors:  B Mullhaupt; P Bauerfeind; M O Kurrer; M Fried
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

2.  Trends in the incidence of human papillomavirus-related noncervical and cervical cancers in Alberta, Canada: a population-based study.

Authors:  Lorraine Shack; Harold Y Lau; Longlong Huang; Corinne Doll; Desirée Hao
Journal:  CMAJ Open       Date:  2014-07-22

3.  Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.

Authors:  K Fakhrian; T Sauer; S Klemm; C Bayer; B Haller; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-11-15       Impact factor: 3.621

4.  Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium.

Authors:  Julia E Heck; Julien Berthiller; Salvatore Vaccarella; Deborah M Winn; Elaine M Smith; Oxana Shan'gina; Stephen M Schwartz; Mark P Purdue; Agnieszka Pilarska; Jose Eluf-Neto; Ana Menezes; Michael D McClean; Elena Matos; Sergio Koifman; Karl T Kelsey; Rolando Herrero; Richard B Hayes; Silvia Franceschi; Victor Wünsch-Filho; Leticia Fernández; Alexander W Daudt; Maria Paula Curado; Chu Chen; Xavier Castellsagué; Gilles Ferro; Paul Brennan; Paolo Boffetta; Mia Hashibe
Journal:  Int J Epidemiol       Date:  2009-12-18       Impact factor: 7.196

5.  Trends in incidence of anal cancer in Denmark.

Authors:  M Frisch; M Melbye; H Møller
Journal:  BMJ       Date:  1993-02-13

Review 6.  Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Authors:  Susanne Hartwig; Stina Syrjänen; Géraldine Dominiak-Felden; Maria Brotons; Xavier Castellsagué
Journal:  BMC Cancer       Date:  2012-01-20       Impact factor: 4.430

7.  Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002.

Authors:  D H Brewster; L A Bhatti
Journal:  Br J Cancer       Date:  2006-05-23       Impact factor: 7.640

8.  An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England.

Authors:  D Robinson; V Coupland; H Møller
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

9.  Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma.

Authors:  M Frisch; B Glimelius; A J van den Brule; J Wohlfahrt; C J Meijer; J M Walboomers; H O Adami; M Melbye
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

10.  Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.

Authors:  T Bjørge; A Engeland; T Luostarinen; J Mork; R E Gislefoss; E Jellum; P Koskela; M Lehtinen; E Pukkala; S Ø Thoresen; J Dillner
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.